Author

P. H. Sugden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

A. Clerk· 3 shared H. O. Alharbi· 3 shared J. J. Cull· 3 shared S. T. Cooper· 3 shared D. N. Meijles· 2 shared M. A. Hardyman· 2 shared O. J. Rackham· 2 shared P. E. Glennon· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPhysiology

A. Clerk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo.

J. J. Cull, S. T. Cooper, H. O. Alharbi, S. Chothani, O. J. Rackham, D. N. Meijles, P. R. Dash, R. Kerkela, N. Ruparelia, P. H. Sugden, A. Clerk

This paper shows that striatin (STRN) in cardiomyocytes is necessary for angiotensin II-induced cardiac hypertrophy and remodelling in mice, but not STRN3.

bioRxiv · Oct 21, 2023 · PreprintPhysiology

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice

H. O. Alharbi, M. A. Hardyman, J. J. Cull, T. Markou, S. T. Cooper, P. E. Glennon, S. J. Fuller, P. H. Sugden, A. Clerk

This study shows that BRAF in cardiomyocytes is essential for male mouse cardiac hypertrophy and fibrosis in hypertension but has opposing effects in physiological hypertrophy, with sex-specific differences.

bioRxiv · Sep 7, 2022Physiology

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo

A. Clerk, D. N. Meijles, M. A. Hardyman, S. J. Fuller, S. P. Chothani, J. J. Cull, S. T. Cooper, H. O. Alharbi, K. Vanezis, L. E. Felkin, T. Markou, S. J. Leonard, S. W. Shaw, O. J. Rackham, S. A. Cook, , P. H. Sugden

This study shows that BRAF activation induces cardiac hypertrophy in mice, and Type 1 RAF inhibitors paradoxically promote hypertrophy by increasing ERK1/2 phosphorylation.

bioRxiv · Aug 14, 2021Biochemistry